Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2019 Sep 26;28(4):449–461. doi: 10.1037/pha0000325

Table 3.

Odds Ratios (ORs) and Significance Testing for Single-Predictor Logistic Regressions (Single; Ns = 1,932–1,946) and Adjusted Odds Ratios (aORs) and Significance Testing for Multivariable Predictor Logistic Regression (Multi; N = 1,912) Examining Correlates of Opioid Antagonist Medication Attitudes (Positive, Neutral, or Negative)a by Positive Versus Neutral and Negative Versus Neutral Pairwise Comparisons

p
Positive versus neutral
Negative versus neutral
Variable Single Multi OR aORb OR aORb
Age .063 .027
 18–29 (ref)c
 30–44 2.52* 2.21 .82 .96
 45–59 2.90** 3.16** .82 .92
 60+ 2.49* 3.21** .70 .83
Gender (female = ref) .669 .91 .88
Race/ethnicity .104
 2+ races 1.76 1.50
 Black—non-Hispanic 1.09 1.73*
 Other—non-Hispanic 1.00 .71
 Hispanic .89 1.59*
 White (ref)
Geographical region .505
 Northeast 1.38 1.16
 Midwest 1.02 1.14
 South .86 1.17
 West
Education level .377 .96 .94
Household income .039 .172 .96* .98 .97* .97
Religiosity .268 1.02 1.12
Spirituality .075 .025 1.00 .89 1.17* 1.15*
Criminal justice history .019 .179
 Arrested, drug court 1.14 .62 2.23** 1.70
 Arrested, no drug court 1.31 1.02 .94 .98
 None (ref)
Psychiatric symptoms .288 1.02 1.00
Quality of life .016 .446 .97** .99 1.00 1.00
Lifetime AUD medication prescription (no = ref) .039 .777 2.29* 1.13 1.31 .85
Lifetime OUD agonist medication prescription (no = ref) <.001 <.001 15.5*** 13.05*** 5.86*** 3.91**
Lifetime OUD antagonist medication prescription (no = ref) .031 .454 25.82** 7.47 9.11 4.58
Inpatient or outpatient treatment (no = ref) .003 .060 1.66** 1.27 .86 .68
History of a co-occurring psychiatric disorder (no = ref) .001 .079 1.91*** 1.44 1.11 .93
Alcohol problem (no = ref) .862 1.03 .93
Cannabis problem (no = ref) .224 .80 1.24
Cocaine problem (no = ref) .689 1.05 1.16
Methamphetamine problem (no = ref) .711 1.06 .85
Opioid problem (no = ref) .116 1.72 1.16
Number problem substances .351 1.06 1.07
Primary substance .350
 None .55 1.54
 Alcohol .75 1.05
 Cannabis .80 1.43
 Cocaine .90 1.30
 Methamphetamine .82 .80
 Opioids (ref)
 Other 1.30 1.79
Years since AOD problem resolution .149 .99 .99
Total abstinence (no = ref) .164 1.01 1.32
Recovery identity (no = ref) .004 .387 1.74*** 1.26 1.16 .96
Any regular 12-step attendance (no = ref) .030 .543 1.53* 1.15 1.33 1.25
Any regular non–12-step MHO attendance (no = ref) .304 1.62 1.03
Past 90-day 12-step MHO attendance (no = ref) .064 .259 1.33 .89 1.76* 1.47
Past 90-day non–12-Step attendance (no = ref) .003 .105 5.04*** 2.86* 2.48 1.83
Any non-MHO recovery support service (no = ref) .158 1.32 1.40

Note. AUD = alcohol use disorder; OUD = opioid use disorder; AOD = alcohol and other drug; MHO = mutual-help organization.

a

Attitude was determined by response to the statement, “It is a good idea for someone with an opioid problem to take an opioid blocking medication like naltrexone/Vivitrol to help them stop using.” Positive attitude = strongly agree or agree; neutral attitude = somewhat agree or somewhat disagree; negative attitude = disagree or strongly disagree.

b

Multivariable-predictor logistic regression models included only the predictors significant at the .10 level in single-predictor models.

c

ref = reference group in logistic regression; if reference group is not specified (e.g., education level), the variable is continuous/ordinal, and the odds ratio represents the increase in log-odds for each 1-unit increase.

*

p < .05.

**

p < .01.

***

p < .001.